BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Suda T, Kageyama K, Sakihara S, Nigawara T. Physiological roles of urocortins, human homologues of fish urotensin I, and their receptors. Peptides 2004;25:1689-701. [PMID: 15476936 DOI: 10.1016/j.peptides.2004.03.027] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Bagosi Z, Csabafi K, Jászberényi M, Telegdy G. The effects of corticotropin-releasing factor and the urocortins on hypothalamic gamma-amino butyric acid release--the impacts on the hypothalamic-pituitary-adrenal axis. Neurochem Int 2012;60:350-4. [PMID: 22306347 DOI: 10.1016/j.neuint.2012.01.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
2 Janeček M, Dabrowska J. Oxytocin facilitates adaptive fear and attenuates anxiety responses in animal models and human studies-potential interaction with the corticotropin-releasing factor (CRF) system in the bed nucleus of the stria terminalis (BNST). Cell Tissue Res 2019;375:143-72. [PMID: 30054732 DOI: 10.1007/s00441-018-2889-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
3 Lastein S, Höglund E, Overli O, Døving KB. Effects of antalarmin, a CRF receptor 1 antagonist, on fright reaction and endocrine stress response in crucian carp (Carassius carassius). J Comp Physiol A Neuroethol Sens Neural Behav Physiol 2008;194:1007-12. [PMID: 18830607 DOI: 10.1007/s00359-008-0372-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
4 Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF 3rd, Petraglia F. Inflammation and pregnancy. Reprod Sci. 2009;16:206-215. [PMID: 19208789 DOI: 10.1177/1933719108329095] [Cited by in Crossref: 545] [Cited by in F6Publishing: 509] [Article Influence: 41.9] [Reference Citation Analysis]
5 Moriyama T, Kageyama K, Kasagi Y, Iwasaki Y, Nigawara T, Sakihara S, Suda T. Differential regulation of corticotropin-releasing factor receptor type 1 (CRF1 receptor) mRNA via protein kinase A and mitogen-activated protein kinase pathways in rat anterior pituitary cells. Molecular and Cellular Endocrinology 2005;243:74-9. [DOI: 10.1016/j.mce.2005.09.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
6 Moffatt JD, Lever R, Page CP. Activation of corticotropin-releasing factor receptor-2 causes bronchorelaxation and inhibits pulmonary inflammation in mice. FASEB J 2006;20:1877-9. [PMID: 16855006 DOI: 10.1096/fj.05-5315fje] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
7 Kageyama K, Iwasaki Y, Daimon M. Hypothalamic Regulation of Corticotropin-Releasing Factor under Stress and Stress Resilience. Int J Mol Sci 2021;22:12242. [PMID: 34830130 DOI: 10.3390/ijms222212242] [Reference Citation Analysis]
8 Bagosi Z, Csabafi K, Karasz G, Jászberényi M, Földesi I, Siska A, Szabó G, Telegdy G. The effects of the urocortins on the hypothalamic-pituitary-adrenal axis - similarities and discordancies between rats and mice. Peptides 2019;112:1-13. [PMID: 30414887 DOI: 10.1016/j.peptides.2018.10.014] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Yao M, Denver RJ. Regulation of vertebrate corticotropin-releasing factor genes. Gen Comp Endocrinol 2007;153:200-16. [PMID: 17382944 DOI: 10.1016/j.ygcen.2007.01.046] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 4.5] [Reference Citation Analysis]
10 Derks NM, Roubos EW, Kozicz T. Presence of estrogen receptor beta in urocortin 1-neurons in the mouse non-preganglionic Edinger-Westphal nucleus. Gen Comp Endocrinol 2007;153:228-34. [PMID: 17632108 DOI: 10.1016/j.ygcen.2007.04.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
11 Kageyama K, Itoi K, Iwasaki Y, Niioka K, Watanuki Y, Yamagata S, Nakada Y, Das G, Suda T, Daimon M. Stimulation of corticotropin-releasing factor gene expression by FosB in rat hypothalamic 4B cells. Peptides 2014;51:59-64. [PMID: 24246425 DOI: 10.1016/j.peptides.2013.11.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
12 Cong B, Zhang L, Gao L, Ni X. Reduced expression of CRH receptor type 1 in upper segment human myometrium during labour. Reprod Biol Endocrinol 2009;7:43. [PMID: 19432998 DOI: 10.1186/1477-7827-7-43] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
13 Boorse GC, Denver RJ. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides. Gen Comp Endocrinol 2006;146:9-18. [PMID: 16413023 DOI: 10.1016/j.ygcen.2005.11.014] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 4.4] [Reference Citation Analysis]
14 Kageyama K, Suda T. Role and action in the pituitary corticotroph of corticotropin-releasing factor (CRF) in the hypothalamus. Peptides 2009;30:810-6. [DOI: 10.1016/j.peptides.2008.12.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
15 Zhou Y, Jiang Y, Wang R, Bai B, Zhou M, Chen T, Cai J, Wang L, Shaw C. PD-sauvagine: a novel sauvagine/corticotropin releasing factor analogue from the skin secretion of the Mexican giant leaf frog, Pachymedusa dacnicolor. Amino Acids 2012;43:1147-56. [PMID: 22134582 DOI: 10.1007/s00726-011-1170-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
16 Wang L, Goebel-Stengel M, Stengel A, Wu SV, Ohning G, Taché Y. Comparison of CRF-immunoreactive neurons distribution in mouse and rat brains and selective induction of Fos in rat hypothalamic CRF neurons by abdominal surgery. Brain Res 2011;1415:34-46. [PMID: 21872218 DOI: 10.1016/j.brainres.2011.07.024] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
17 Torricelli M, De Falco G, Florio P, Rossi M, Leucci E, Viganò P, Leoncini L, Petraglia F. Secretory endometrium highly expresses urocortin messenger RNA and peptide: possible role in the decidualization process. Hum Reprod. 2007;22:92-96. [PMID: 16920724 DOI: 10.1093/humrep/del331] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
18 Martinon D, Dabrowska J. Corticotropin-Releasing Factor Receptors Modulate Oxytocin Release in the Dorsolateral Bed Nucleus of the Stria Terminalis (BNST) in Male Rats. Front Neurosci 2018;12:183. [PMID: 29618970 DOI: 10.3389/fnins.2018.00183] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
19 Kageyama K, Hanada K, Nigawara T, Furukawa K, Terui K, Ogura E, Motomura S, Suda T. Inhibitory effects of glucocorticoids on urocortin-mediated increases in interleukin-6 gene expression in rat aortic smooth muscle cells. Peptides 2007;28:1059-67. [PMID: 17346851 DOI: 10.1016/j.peptides.2007.02.002] [Reference Citation Analysis]
20 Kageyama K, Hanada K, Moriyama T, Nigawara T, Sakihara S, Suda T. G protein-coupled receptor kinase 2 involvement in desensitization of corticotropin-releasing factor (CRF) receptor type 1 by CRF in murine corticotrophs. Endocrinology 2006;147:441-50. [PMID: 16195412 DOI: 10.1210/en.2005-0376] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
21 Yamagata S, Kageyama K, Akimoto K, Watanuki Y, Suda T, Daimon M. Regulation of corticotropin-releasing factor and urocortin 2/3 mRNA by leptin in hypothalamic N39 cells. Peptides 2013;50:1-7. [PMID: 24083959 DOI: 10.1016/j.peptides.2013.09.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
22 Bagosi Z, Palotai M, Simon B, Bokor P, Buzás A, Balangó B, Pintér D, Jászberényi M, Csabafi K, Szabó G. Selective CRF2 receptor agonists ameliorate the anxiety- and depression-like state developed during chronic nicotine treatment and consequent acute withdrawal in mice. Brain Res 2016;1652:21-9. [PMID: 27693397 DOI: 10.1016/j.brainres.2016.09.044] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
23 Kageyama K, Hanada K, Takayasu S, Iwasaki Y, Sakihara S, Nigawara T, Suda T. Involvement of regulatory elements on corticotropin-releasing factor gene promoter in nypothalamic 4B cells. J Endocrinol Invest 2008;31:1079-85. [DOI: 10.1007/bf03345656] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
24 Florio P, Bruni L, De Falco C, Filardi G, Torricelli M, Reis FM, Galleri L, Voltolini C, Bocchi C, De Leo V, Petraglia F. Evaluation of Endometrial Urocortin Secretion for Prediction of Pregnancy after Intrauterine Insemination. Clinical Chemistry 2008;54:350-5. [DOI: 10.1373/clinchem.2007.094987] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
25 Tao J, Zhang Y, Soong TW, Li S. Expression of Urocortin 2 and its Inhibitory Effects on Intracellular Ca2+ Via L-Type Voltage-Gated Calcium Channels in Rat Pheochromocytoma (PC12) Cells. Neuropsychopharmacol 2006;31:2600-9. [DOI: 10.1038/sj.npp.1301123] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
26 Kageyama K, Hanada K, Moriyama T, Imaizumi T, Satoh K, Suda T. Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells. Mol Cell Endocrinol 2007;263:90-102. [PMID: 17027144 DOI: 10.1016/j.mce.2006.08.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
27 Kim Y, Park MK, Uhm D, Chung S. Modulation of T-type Ca2+ channels by corticotropin-releasing factor through protein kinase C pathway in MN9D dopaminergic cells. Biochemical and Biophysical Research Communications 2007;358:796-801. [DOI: 10.1016/j.bbrc.2007.04.198] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
28 Saavedra JM, Pavel J. Angiotensin II AT1 receptor antagonists inhibit the angiotensin-CRF-AVP axis and are potentially useful for the treatment of stress-related and mood disorders. Drug Dev Res 2005;65:237-69. [DOI: 10.1002/ddr.20027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
29 Kageyama K, Kimura R, Suga S, Ogawa Y, Suda T, Wakui M. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells. Peptides 2006;27:1814-9. [PMID: 16513211 DOI: 10.1016/j.peptides.2006.01.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
30 Catalani E, De Palma C, Perrotta C, Cervia D. Current Evidence for a Role of Neuropeptides in the Regulation of Autophagy. Biomed Res Int 2017;2017:5856071. [PMID: 28593174 DOI: 10.1155/2017/5856071] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
31 Kaser-Eichberger A, Platzl C, Wolfmeier H, Trost A, Horn A, Barnerssoi M, Strohmaier C, Schroedl F. Urocortin-positive nerve fibres and cells are present in the human choroid. Br J Ophthalmol 2022:bjophthalmol-2021-320697. [PMID: 35217514 DOI: 10.1136/bjophthalmol-2021-320697] [Reference Citation Analysis]
32 Grammatopoulos DK. Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction. Br J Pharmacol 2012;166:85-97. [PMID: 21883143 DOI: 10.1111/j.1476-5381.2011.01631.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 7.5] [Reference Citation Analysis]
33 Florio P, Torres PB, Torricelli M, Toti P, Vale W, Petraglia F. Human endometrium expresses urocortin II and III messenger RNA and peptides. Fertility and Sterility 2006;86:1766-70. [DOI: 10.1016/j.fertnstert.2006.05.041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
34 Lee S, Braden B, Kang SS, Rivier C. Urocortins are present in the rat testis. Neuropeptides 2011;45:131-7. [PMID: 21256589 DOI: 10.1016/j.npep.2010.12.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
35 Bagosi Z, Csabafi K, Palotai M, Jászberényi M, Földesi I, Gardi J, Szabó G, Telegdy G. The interaction of Urocortin II and Urocortin III with amygdalar and hypothalamic cotricotropin-releasing factor (CRF) – Reflections on the regulation of the hypothalamic–pituitary–adrenal (HPA) axis. Neuropeptides 2013;47:333-8. [DOI: 10.1016/j.npep.2013.07.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
36 Kageyama K, Hanada K, Suda T. Differential regulation of urocortins1–3 mRNA in human umbilical vein endothelial cells. Regulatory Peptides 2009;155:131-8. [DOI: 10.1016/j.regpep.2009.02.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
37 Bagosi Z, Karasz G, Czébely-Lénárt A, Csabafi K, Jászberényi M, Telegdy G. The effects of CRF and urocortins on the sociability of mice. Brain Res 2017;1663:114-22. [PMID: 28315311 DOI: 10.1016/j.brainres.2017.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
38 Kageyama K, Hanada K, Suda T. Differential regulation and roles of urocortins in human adrenal H295R cells. Regul Pept 2010;162:18-25. [PMID: 20171993 DOI: 10.1016/j.regpep.2010.02.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
39 Kageyama K, Teui K, Tamasawa N, Suda T. Regulation and roles of urocortins in the vascular system. Int J Endocrinol 2012;2012:873723. [PMID: 22654906 DOI: 10.1155/2012/873723] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Bagosi Z, Czébely-lénárt A, Karasz G, Csabafi K, Jászberényi M, Telegdy G. The effects of CRF and urocortins on the preference for social novelty of mice. Behavioural Brain Research 2017;324:146-54. [DOI: 10.1016/j.bbr.2017.02.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
41 Kaprara A, Pazaitou-Panayiotou K, Kortsaris A, Chatzaki E. The corticotropin releasing factor system in cancer: expression and pathophysiological implications. Cell Mol Life Sci. 2010;67:1293-1306. [PMID: 20143250 DOI: 10.1007/s00018-010-0265-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
42 Watanuki Y, Kageyama K, Takayasu S, Matsuzaki Y, Iwasaki Y, Daimon M. Ultraviolet B radiation-stimulated urocortin 1 is involved in tyrosinase-related protein 1 production in human melanoma HMV-II cells. Peptides 2014;61:93-7. [PMID: 25240771 DOI: 10.1016/j.peptides.2014.09.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
43 Kageyama K. Regulation of gonadotropins by corticotropin-releasing factor and urocortin. Front Endocrinol (Lausanne) 2013;4:12. [PMID: 23431022 DOI: 10.3389/fendo.2013.00012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
44 Kageyama K, Hasegawa G, Akimoto K, Yamagata S, Tamasawa N, Suda T. Differential regulation of gonadotropin-releasing hormone by corticotropin-releasing factor family peptides in hypothalamic N39 cells. Peptides 2012;33:149-55. [PMID: 22138165 DOI: 10.1016/j.peptides.2011.11.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
45 Kageyama K, Sakihara S, Yamashita M, Takahashi K, Kawashima S, Tanabe J, Tsutaya S, Yasujima M, Suda T. A case of multiple endocrine neoplasia type II accompanied by thyroid medullary carcinoma and pheochromocytomas expressing corticotropin-releasing factor and urocortins. Am J Med Sci 2008;335:398-402. [PMID: 18480660 DOI: 10.1097/MAJ.0b013e31815200f8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
46 Vedder H. Physiology of the Hypothalamic–Pituitary–Adrenocortical Axis. The Hypothalamus-Pituitary-Adrenal Axis. Elsevier; 2007. pp. 17-31. [DOI: 10.1016/s1567-7443(07)00202-5] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
47 Pan W, Kastin AJ. Urocortin and the brain. Prog Neurobiol 2008;84:148-56. [PMID: 18078706 DOI: 10.1016/j.pneurobio.2007.10.008] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 4.1] [Reference Citation Analysis]
48 Zhang X, Yuan M, Lu W. Individuality in flounder ( Paralichthys olivaceus ): Differential responses of immune–endocrine during temperature stress in head kidney. Aquaculture Research. [DOI: 10.1111/are.15667] [Reference Citation Analysis]
49 Singh R, Rai U. Immunomodulatory role of urotensins in teleost Channa punctatus. General and Comparative Endocrinology 2011;170:613-21. [DOI: 10.1016/j.ygcen.2010.11.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
50 Calle M, Jenks BG, Corstens GJ, Veening JG, Barendregt HP, Roubos EW. Localisation and physiological regulation of corticotrophin-releasing factor receptor 1 mRNA in the Xenopus laevis brain and pituitary gland. J Neuroendocrinol 2006;18:797-805. [PMID: 16965298 DOI: 10.1111/j.1365-2826.2006.01475.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
51 Guan X, Wang L, Chen CL, Guan Y, Li S. Roles of two subtypes of corticotrophin-releasing factor receptor in the corticostriatal long-term potentiation under cocaine withdrawal condition. J Neurochem 2010;115:795-803. [PMID: 20807310 DOI: 10.1111/j.1471-4159.2010.06981.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
52 Takei Y, Kawakoshi A, Tsukada T, Yuge S, Ogoshi M, Inoue K, Hyodo S, Bannai H, Miyano S. Contribution of comparative fish studies to general endocrinology: structure and function of some osmoregulatory hormones. J Exp Zool A Comp Exp Biol 2006;305:787-98. [PMID: 16902950 DOI: 10.1002/jez.a.309] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
53 Kageyama K, Hanada K, Nigawara T, Furukawa K, Terui K, Ogura E, Motomura S, Suda T. Inhibitory effects of glucocorticoids on urocortin-mediated increases in interleukin-6 gene expression in rat aortic smooth muscle cells. Peptides 2007;28:1059-67. [DOI: 10.1016/j.peptides.2007.02.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Kawashima S, Sakihara S, Kageyama K, Nigawara T, Suda T. Corticotropin-releasing factor (CRF) is involved in the acute anorexic effect of α-melanocyte-stimulating hormone: A study using CRF-deficient mice. Peptides 2008;29:2169-74. [DOI: 10.1016/j.peptides.2008.09.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
55 Kageyama K, Akimoto K, Suda T. Corticotrophin-releasing factor gene transcription is directly activated after deprivation of glucocorticoids in hypothalamic cells. J Neuroendocrinol 2010;22:971-8. [PMID: 20626567 DOI: 10.1111/j.1365-2826.2010.02048.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
56 Nozu T, Okumura T. Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome. J Gastroenterol. 2015;50:819-830. [PMID: 25962711 DOI: 10.1007/s00535-015-1086-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
57 Stengel A, Taché YF. Activation of Brain Somatostatin Signaling Suppresses CRF Receptor-Mediated Stress Response. Front Neurosci 2017;11:231. [PMID: 28487631 DOI: 10.3389/fnins.2017.00231] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
58 Kageyama K, Hanada K, Nigawara T, Moriyama T, Terui K, Sakihara S, Suda T. Urocortin induces interleukin-6 gene expression via cyclooxygenase-2 activity in aortic smooth muscle cells. Endocrinology 2006;147:4454-62. [PMID: 16777977 DOI: 10.1210/en.2006-0008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
59 Watanuki Y, Takayasu S, Kageyama K, Iwasaki Y, Sakihara S, Terui K, Nigawara T, Suda T. Involvement of Nurr-1/Nur77 in corticotropin-releasing factor/urocortin1-induced tyrosinase-related protein 1 gene transcription in human melanoma HMV-II cells. Molecular and Cellular Endocrinology 2013;370:42-51. [DOI: 10.1016/j.mce.2013.01.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
60 Kageyama K, Sakihara S, Suda T. Regulation and role of p21-activated kinase 3 by corticotropin-releasing factor in mouse pituitary. Regulatory Peptides 2009;152:88-94. [DOI: 10.1016/j.regpep.2008.10.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
61 Kageyama K, Iwasaki Y, Watanuki Y, Niioka K, Daimon M. Differential Effects of Fkbp4 and Fkbp5 on Regulation of the Proopiomelanocortin Gene in Murine AtT-20 Corticotroph Cells. Int J Mol Sci 2021;22:5724. [PMID: 34072036 DOI: 10.3390/ijms22115724] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Bagosi Z, Balangó B, Pintér D, Csabafi K, Jászberényi M, Szabó G, Telegdy G. The effects of CRF and urocortins on the hippocampal glutamate release. Neurochem Int 2015;90:67-71. [PMID: 26216727 DOI: 10.1016/j.neuint.2015.07.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
63 Bagosi Z, Csabafi K, Balangó B, Pintér D, Szolomájer-Csikós O, Bozsó Z, Tóth G, Telegdy G, Szabó G. Anxiolytic- and antidepressant-like actions of Urocortin 2 and its fragments in mice. Brain Res 2018;1680:62-8. [PMID: 29247629 DOI: 10.1016/j.brainres.2017.12.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]